Recent literature data suggest beneficial effects of dietary fats in patients with cancers, in particular polyunsaturated fatty acids (PUFAs). Milled mix of flax, sesame and pumpkin seeds provides a high amount of PUFAs and a desirable n-6/n-3 PUFAs ratio.
Cancers are characterized by inflammation and alternations in lipid and fatty acid metabolism. Patients with non-Hodgkin lymphoma have impaired fatty acid profiles, low level of PUFAs, and high n-6/n-3 PUFAs ratio. Moreover, these changes are related to clinical outcome. Flax seeds, sesame and pumpkin seeds are rich sources of PUFAs. Dietary intake of milled mix of these seeds has been shown to decrease inflammation and improve PUFAs status in patients on hemodialysis and to decrease breast cancer risk. The study design is single-blind, controlled, randomized nutritional intervention. The participants are randomly assigned into intervention and control group before starting chemotherapy. All patients receive nutritional counseling to achieve a daily energy and protein intake according to recommended dietary allowances, with (intervention) or without (control) of milled seed mix.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
Dietary intervention with or without seed mix
Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade
Belgrade, Serbia
RECRUITINGChange in disease status
Remission, stable disease or progression
Time frame: Baseline, 5 months, 1 year
Change in quality of life questionnaire scores
Assessed by standardized questionnaires
Time frame: Baseline, 5 months, 1 year
Changes in body weight
Changes in body weight measured by bio-impedance analyzer, from baseline to endpoint
Time frame: Baseline, 5 months, 1 year
Changes in leukocyte count
Measures of leukocyte count
Time frame: Baseline, 5 months, 1 year
Changes in lipid profiles
Changes in lipid profiles (cholesterol, HDL, LDL and triglycerides) from baseline to endpoint
Time frame: Baseline, 5 months, 1 year
Changes in plasma fatty acids
Changes in plasma fatty acids profiles from baseline to endpoint
Time frame: Baseline, 5 months, 1 year
Changes in CRP
Changes in CRP from baseline to endpoint
Time frame: Baseline, 5 months, 1 year
Changes in interleukin (IL)-6
Changes in interleukin (IL)-6 from baseline to endpoint
Time frame: Baseline, 5 months, 1 year
Changes in parameters of oxidative stress
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Measures of activities of the following enzymes: SOD, catalase, glutathion peroxidase and glutation reductase
Time frame: Baseline, 5 months